ARCHIVES

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

This article is from The Cancer Letter archive.

Vol. 33 No. 13 | April 6, 2007

Download PDF Visit The Full Archive

Related Articles

National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM.

November 5, 2004

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003

DCT Advisors Approve Grants Program For Trials Of BRMs

March 10, 1995

ORI Withdraws Requirement For Research Ethics Courses.

February 23, 2001

CCOP RFA On The Street; Addition Of Cancer Control Research Adds New Dimension To Program

July 18, 1986

Cancer Informatics: NCI Writing Dictionary To Standardize Data Reported In Trials

November 13, 1998